The DNA sequencing company also cut its 2025 earnings outlook to reflect the impact of tariffs on its business.

Good day, ladies and gentlemen, and welcome to the first-quarter 2025 Illumina earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would ...

Core Illumina revenue of $1.04 billion for Q1 2025, down 1% from Q1 2024 (flat on a constant currency basis) GAAP operating margin of 15.8% and non-GAAP operating ...

Q1 2025 Management View CEO Jacob Thaysen highlighted that Q1 revenue and EPS came in at the upper end of guidance. He emphasized the strong performance of the NovaSeq X instruments, with over 60 ...

Although the revenue and EPS for Illumina (ILMN) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street ...

The global Single Cell Analysis Market , valued at US$3.55 billion in 2024, is forecasted to grow at a robust CAGR of 14.7%, ...

Q1 2025 Management View CEO Michael Egholm highlighted that Standard BioTools delivered Q1 2025 revenues of $40.8 million, aligned with their plan despite a challenging operating backdrop. He ...

Detailed price information for Texas Instruments (TXN-Q) from The Globe and Mail including charting and trades.

Beyond analysts' top -and-bottom-line estimates for Illumina (ILMN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the ...

“The Holy Spirit chose him so that he could be an instrument of Christ in today’s world,” the cardinal said. He further pointed to Francis’ regular contention — articulated first in ...

Investors in Illumina Inc (Symbol: ILMN) saw new options become available today, for the June 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ILMN ...